IDPTClinical Trials•globenewswire•
Indaptus Therapeutics Provides Clinical Update
Sentiment:Neutral (45)
Summary
(IDPT) Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 4, 2025 by globenewswire